Most therapeutic trials are nowadays "Intent to treat". So subject would receive either standardized tx or experimental tx in th e randomization. Many of them also have crossovers such that when measurable (as defined by the protocol) benefit is seen, standard tx based subjects can be moved over to the experimental arm
No comments yet.